MiR-25 is activated by WNT/β-catenin signaling to promote HCC cell EMT, migration and invasion, through direct targeting of the Rho GDP dissociation inhibitor alpha (RhoGDI1) both in vitro and in vivo. The gene discussed is ARHGDIA; the disease is hepatocellular carcinoma.